1833 related articles for article (PubMed ID: 35725836)
1. Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy.
Gao W; Wang X; Zhou Y; Wang X; Yu Y
Signal Transduct Target Ther; 2022 Jun; 7(1):196. PubMed ID: 35725836
[TBL] [Abstract][Full Text] [Related]
2. Ferroptosis, necroptosis, and pyroptosis in the tumor microenvironment: Perspectives for immunotherapy of SCLC.
Niu X; Chen L; Li Y; Hu Z; He F
Semin Cancer Biol; 2022 Nov; 86(Pt 3):273-285. PubMed ID: 35288298
[TBL] [Abstract][Full Text] [Related]
3. Ferroptosis, necroptosis, and pyroptosis in anticancer immunity.
Tang R; Xu J; Zhang B; Liu J; Liang C; Hua J; Meng Q; Yu X; Shi S
J Hematol Oncol; 2020 Aug; 13(1):110. PubMed ID: 32778143
[TBL] [Abstract][Full Text] [Related]
4. Ferroptosis, pyroptosis and necroptosis in hepatocellular carcinoma immunotherapy: Mechanisms and immunologic landscape (Review).
Liu RJ; Yu XD; Yan SS; Guo ZW; Zao XB; Zhang YS
Int J Oncol; 2024 Jun; 64(6):. PubMed ID: 38757345
[TBL] [Abstract][Full Text] [Related]
5. Targeting novel regulated cell death: Ferroptosis, pyroptosis and necroptosis in anti-PD-1/PD-L1 cancer immunotherapy.
Yu L; Huang K; Liao Y; Wang L; Sethi G; Ma Z
Cell Prolif; 2024 Apr; ():e13644. PubMed ID: 38594879
[TBL] [Abstract][Full Text] [Related]
6. Regulated Necrotic Cell Death in Alternative Tumor Therapeutic Strategies.
Woo Y; Lee HJ; Jung YM; Jung YJ
Cells; 2020 Dec; 9(12):. PubMed ID: 33348858
[TBL] [Abstract][Full Text] [Related]
7. Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research.
Tong X; Tang R; Xiao M; Xu J; Wang W; Zhang B; Liu J; Yu X; Shi S
J Hematol Oncol; 2022 Dec; 15(1):174. PubMed ID: 36482419
[TBL] [Abstract][Full Text] [Related]
8. Non-apoptotic regulated cell death mediates reprogramming of the tumour immune microenvironment by macrophages.
Sun C; Zhan J; Li Y; Zhou C; Huang S; Zhu X; Huang K
J Cell Mol Med; 2024 Apr; 28(8):e18348. PubMed ID: 38652105
[TBL] [Abstract][Full Text] [Related]
9. Inflammation-related pyroptosis, a novel programmed cell death pathway, and its crosstalk with immune therapy in cancer treatment.
Hsu SK; Li CY; Lin IL; Syue WJ; Chen YF; Cheng KC; Teng YN; Lin YH; Yen CH; Chiu CC
Theranostics; 2021; 11(18):8813-8835. PubMed ID: 34522213
[TBL] [Abstract][Full Text] [Related]
10. The application of nanoparticles-based ferroptosis, pyroptosis and autophagy in cancer immunotherapy.
Deng W; Shang H; Tong Y; Liu X; Huang Q; He Y; Wu J; Ba X; Chen Z; Chen Y; Tang K
J Nanobiotechnology; 2024 Mar; 22(1):97. PubMed ID: 38454419
[TBL] [Abstract][Full Text] [Related]
11. Targeting regulated cell death (RCD) with small-molecule compounds in triple-negative breast cancer: a revisited perspective from molecular mechanisms to targeted therapies.
Liao M; Qin R; Huang W; Zhu HP; Peng F; Han B; Liu B
J Hematol Oncol; 2022 Apr; 15(1):44. PubMed ID: 35414025
[TBL] [Abstract][Full Text] [Related]
12. Programmed Cell Death Tunes Tumor Immunity.
Liu J; Hong M; Li Y; Chen D; Wu Y; Hu Y
Front Immunol; 2022; 13():847345. PubMed ID: 35432318
[TBL] [Abstract][Full Text] [Related]
13. Heme Oxgenase-1, a Cardinal Modulator of Regulated Cell Death and Inflammation.
Ryter SW
Cells; 2021 Feb; 10(3):. PubMed ID: 33671004
[TBL] [Abstract][Full Text] [Related]
14. Targeted therapy for non-small-cell lung cancer: New insights into regulated cell death combined with immunotherapy.
Li S; Wang A; Wu Y; He S; Shuai W; Zhao M; Zhu Y; Hu X; Luo Y; Wang G
Immunol Rev; 2024 Jan; 321(1):300-334. PubMed ID: 37688394
[TBL] [Abstract][Full Text] [Related]
15. Ferroptosis, necroptosis, and pyroptosis in cancer: Crucial cell death types in radiotherapy and post-radiotherapy immune activation.
Wang Y; Wang Y; Pan J; Gan L; Xue J
Radiother Oncol; 2023 Jul; 184():109689. PubMed ID: 37150447
[TBL] [Abstract][Full Text] [Related]
16. Fueling the Fire: Inflammatory Forms of Cell Death and Implications for Cancer Immunotherapy.
Rosenbaum SR; Wilski NA; Aplin AE
Cancer Discov; 2021 Feb; 11(2):266-281. PubMed ID: 33451983
[TBL] [Abstract][Full Text] [Related]
17. Cell Death Pathway Regulation by Functional Nanomedicines for Robust Antitumor Immunity.
Li Y; Guo Y; Zhang K; Zhu R; Chen X; Zhang Z; Yang W
Adv Sci (Weinh); 2024 Jan; 11(3):e2306580. PubMed ID: 37984863
[TBL] [Abstract][Full Text] [Related]
18. Non-Apoptotic Cell Death Signaling Pathways in Melanoma.
Hartman ML
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340261
[TBL] [Abstract][Full Text] [Related]
19. The Induction Mechanism of Ferroptosis, Necroptosis, and Pyroptosis in Inflammatory Bowel Disease, Colorectal Cancer, and Intestinal Injury.
Zhou P; Zhang S; Wang M; Zhou J
Biomolecules; 2023 May; 13(5):. PubMed ID: 37238692
[TBL] [Abstract][Full Text] [Related]
20. Nanomedicine-mediated regulated cell death in cancer immunotherapy.
Sun Y; Lian T; Huang Q; Chang Y; Li Y; Guo X; Kong W; Yang Y; Zhang K; Wang P; Wang X
J Control Release; 2023 Dec; 364():174-194. PubMed ID: 37871752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]